Investing in Single Stocks vs. ETFs in Weight Loss Space

There may be a stronger case to invest in single stocks over exchange-traded funds in the weight loss space.

Amplify ETFs and Roundhill Investments each filed a prospectus last week to launch funds focused on weight loss companies, a move that Strategas ETF and technical strategist Todd Sohn believes hinges on the performance of two dominant stocks: "The main holdings are going to be Lilly and Novo Nordisk, and probably one or two other big names … along with some of the manufacturers down the supply chain," he told CNBC's. With just two players currently at the forefront of the U.S. obesity drug market, ProShares' Simeon Hyman questions the relevance of weight loss ETFs for investors looking to buy into the industry. "I think that's one of the challenges whenever you see an innovation like this," the firm's global investment strategist said in the same interview. "If the benefits are going to incumbents, then maybe there isn't a theme per se that needs to be exploited.

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

Jim Cramer’s guide to investing: How to start picking individual stocksCNBC's Jim Cramer advised beginner investors on how to successfully begin picking individual stocks.
출처: CNBC - 🏆 12. / 72 더 많은 것을 읽으십시오 »

Recession Proof Stocks - Investing.comIdentify recession proof stocks, companies that tend to experience relatively steady demand in both good times and bad, providing steady and consistent returns.
출처: Investingcom - 🏆 450. / 53 더 많은 것을 읽으십시오 »

Top Dividend Stocks - Investing.comDiscover the top dividend stocks for long-term growth and steady income. Research and compare the performance.
출처: Investingcom - 🏆 450. / 53 더 많은 것을 읽으십시오 »